Endurant Capital Management LP - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$1,110,640
-41.6%
353,707
-4.0%
1.00%
-39.9%
Q2 2023$1,901,140
-29.6%
368,438
-28.1%
1.66%
+19.6%
Q1 2023$2,702,161
-9.6%
512,744
-51.8%
1.39%
+14.3%
Q4 2022$2,989,708
-32.3%
1,063,953
-0.0%
1.21%
-15.6%
Q3 2022$4,417,000
+44.5%
1,064,295
+40.0%
1.44%
+34.2%
Q2 2022$3,056,000
-33.2%
760,228
-17.7%
1.07%
-11.0%
Q1 2022$4,574,000
-8.5%
923,963
+28.8%
1.20%
-0.1%
Q4 2021$4,998,000
-18.1%
717,143
+17.5%
1.21%
-13.2%
Q3 2021$6,104,000
-24.6%
610,401
+6.9%
1.39%
-37.5%
Q2 2021$8,096,000
+12.4%
570,970
+30.1%
2.22%
+18.5%
Q1 2021$7,203,000
+19.8%
438,933
+51.1%
1.88%
-13.4%
Q4 2020$6,013,000
-5.6%
290,465
-65.3%
2.17%
+15.1%
Q3 2020$6,371,000
+1.3%
837,137
+10.8%
1.88%
+446.1%
Q2 2020$6,292,000
+121.3%
755,330
+5.5%
0.34%
-69.3%
Q1 2019$2,843,000
+207.0%
716,124
+207.7%
1.12%
+129.9%
Q4 2018$926,000
-55.5%
232,727
-23.0%
0.49%
-47.1%
Q3 2018$2,079,000
+115.7%
302,153
+111.6%
0.92%
+121.3%
Q2 2018$964,000
-17.0%
142,775
-20.0%
0.42%
-3.7%
Q1 2018$1,162,000178,4610.43%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2021
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,804,788$15,105,00043.34%
Versant Venture Management, LLC 2,215,384$8,795,074,0002.90%
Opaleye Management Inc. 1,900,000$7,543,0002.09%
SV Health Investors, LLC 628,236$2,494,0001.46%
Endurant Capital Management LP 716,124$2,843,0001.12%
DELTEC ASSET MANAGEMENT LLC 824,747$3,274,0000.72%
NOTTINGHAM ADVISORS, INC. 146,946$583,0000.08%
Jump Trading, LLC 39,255$156,0000.05%
Man Group plc 1,723,456$6,842,0000.03%
JGP Global Gestao de Recursos Ltda. 13,880$55,0000.02%
View complete list of OCULAR THERAPEUTIX INC shareholders